Combinations of statins, aspirins and β-blockers improve survival in patients with ischaemic heart disease, say the UK authors of a case-control analysis.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Correspondence:
Online responses are no longer available. Please refer to our instructions for authors page for more information.